For example, MEGF10 is postulated to act as a tumour repressor gene in neuroblastoma17, while genetic aberrations affecting MEGF10 are associated with myopathy18,19, areflexia, respiratory distress and dysphagia (EMARDD)20. The gene discussed is MEGF10; the disease is Areflexia.